{"protocolSection": {"identificationModule": {"nctId": "NCT01213706", "orgStudyIdInfo": {"id": "20090748"}, "organization": {"fullName": "University of Miami", "class": "OTHER"}, "briefTitle": "Effect of Whole Body Periodic Acceleration on Airway Endothelial Function", "officialTitle": "Effect of Whole Body Periodic Acceleration on Airway Endothelial Function in Healthy Smokers, Non-smokers and Asthmatics"}, "statusModule": {"statusVerifiedDate": "2016-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2009-10"}, "primaryCompletionDateStruct": {"date": "2011-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2011-05", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-10-01", "studyFirstSubmitQcDate": "2010-10-01", "studyFirstPostDateStruct": {"date": "2010-10-04", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-03-25", "resultsFirstSubmitQcDate": "2014-09-05", "resultsFirstPostDateStruct": {"date": "2014-09-12", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2016-07-07", "lastUpdatePostDateStruct": {"date": "2016-08-10", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Adam Wanner", "investigatorTitle": "Professor of Medicine", "investigatorAffiliation": "University of Miami"}, "leadSponsor": {"name": "University of Miami", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "In the present proposal the investigators wish to assess the effect of a single session with the device known as Exer-Rest\u00ae which applies Whole Body Periodic Acceleration (WBPA) on baseline airway blood flow (Qaw) and in Qaw variation, in current smokers, glucocorticoid-na\u00efve asthmatics, and age-matched healthy never-smokers, with the expectation that the treatment will transiently increase the Qaw, and to a greater extent in the current smokers and patients with asthma who have endothelial dysfunction.", "detailedDescription": "Endothelial shear stress activates nitric oxide synthase (NOS), leading to endothelium-dependent vasodilation. This can be accomplished through exercise or with a device known as Exer-Rest\u00ae which applies Whole Body Periodic Acceleration (WBPA) that is also called pGz. WBPA produces systemic vasodilation, by exerting shear stress on the vascular endothelium, activating endothelial NOS and releasing NO in animal models and human subjects. Cigarette smoking is associated with attenuated vascular relaxation responses in the systemic circulation. Patients with asthma also exhibit endothelial dysfunction in the airway. In this study the investigators wish to assess the effect of a single pGz session on baseline Qaw and delta Qaw in current smokers, glucocorticoid-na\u00efve asthmatics, and age-matched healthy never-smokers to test if this treatment will increase the vascular relaxation responses."}, "conditionsModule": {"conditions": ["Healthy", "Smokers", "Asthma"], "keywords": ["airway blood flow", "albuterol", "Whole Body Periodic Acceleration (WBPA)", "Nitric Oxide", "Endothelial Dysfunction"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 45, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Whole Body Periodic Acceleration (WBPA)", "type": "EXPERIMENTAL", "description": "All subjects will be performing this procedure. WBPA in spinal axis (pGz) will be administered with a platform that resembles a bed. The platform moves in a repetitive head-to-foot direction at 140 times a minute, producing 0.22 g.", "interventionNames": ["Device: Whole Body Periodic Acceleration (WBPA)", "Device: Sham WBPA"]}, {"label": "Sham WBPA", "type": "EXPERIMENTAL", "description": "Sham WBPA :\n\nAll subjects will be performing this procedure before the WBPA. The subjects will rest for 45 minutes in the Whole Body Periodic Acceleration (WBPA) platform without movement as a control challenge.", "interventionNames": ["Device: Whole Body Periodic Acceleration (WBPA)", "Device: Sham WBPA"]}], "interventions": [{"type": "DEVICE", "name": "Whole Body Periodic Acceleration (WBPA)", "description": "Subjects will undergo to the Whole Body Periodic Acceleration platform for treatment (shaking period) for 45 min.", "armGroupLabels": ["Sham WBPA", "Whole Body Periodic Acceleration (WBPA)"]}, {"type": "DEVICE", "name": "Sham WBPA", "description": "The subjects will rest for 45 minutes in the Whole Body Periodic Acceleration (WBPA) platform without movement as a control challenge.", "armGroupLabels": ["Sham WBPA", "Whole Body Periodic Acceleration (WBPA)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Airway Blood Flow Response to Albuterol", "description": "Airway Blood Flow will be measured before and 15 minutes after the 180 mcg of albuterol inhalation.", "timeFrame": "Qaw post minus Qaw pre albuterol after WBPA or Sham WBPA"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n15 healthy never-smokers, 15 smokers (\\> than 1 year smoke history) and 15 never-smokers asthmatics; FEV1 \\> 80% (except for asthmatics subjets)\n\nExclusion Criteria:\n\nWomen of childbearing potential who do not accepted birth control measures; pregnant and breast feeding; cardiovascular disease or use of cardiovascular drugs; respiratory infection during the 4 weeks preceding the study; use of inhaled or systemic glucocorticoids, leukotriene modifiers or theophyllines in asthmatics; FEV1 \\< 80% on the screening day (excepted for asthmatics subjets)", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "20 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Adam Wanner, MD", "affiliation": "University of Miami", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Pulmonary Human Research Laboratory, University of Miami Miller School of Medicine", "city": "Miami", "state": "Florida", "zip": "33136", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}]}, "referencesModule": {"references": [{"pmid": "15653959", "type": "BACKGROUND", "citation": "Sackner MA, Gummels E, Adams JA. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest. 2005 Jan;127(1):30-9. doi: 10.1378/chest.127.1.30."}, {"pmid": "16236957", "type": "BACKGROUND", "citation": "Sackner MA, Gummels E, Adams JA. Effect of moderate-intensity exercise, whole-body periodic acceleration, and passive cycling on nitric oxide release into circulation. Chest. 2005 Oct;128(4):2794-803. doi: 10.1378/chest.128.4.2794."}, {"pmid": "18159115", "type": "BACKGROUND", "citation": "Matsumoto T, Fujita M, Tarutani Y, Yamane T, Takashima H, Nakae I, Horie M. Whole-body periodic acceleration enhances brachial endothelial function. Circ J. 2008 Jan;72(1):139-43. doi: 10.1253/circj.72.139."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "SHAM WBPA Then WBPA"}], "periods": [{"title": "Sham WBPA", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}, {"title": "Washout (1 Hour)", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}, {"title": "WBPA", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Whole Body Periodic Acceleration (WBPA)", "description": "Whole Body Periodic Acceleration (WBPA) in spinal axis (pGz) will be administered with a platform that resembles a bed. The platform moves in a repetitive head-to-foot direction at 140 times a minute, producing 0.22 g. These settings have been shown to release NO into the circulation.\n\nWhole Body Periodic Acceleration (WBPA): Subjects will undergo to the Whole Body Periodic Acceleration platform for treatment (shaking period) for 45 min."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "45"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "45"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "18"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "27"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "41"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "45"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Airway Blood Flow Response to Albuterol", "description": "Airway Blood Flow will be measured before and 15 minutes after the 180 mcg of albuterol inhalation.", "populationDescription": "controls n =15, smokers N=15 , asthma N=15", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "\u03bcl/min/ml", "timeFrame": "Qaw post minus Qaw pre albuterol after WBPA or Sham WBPA", "groups": [{"id": "OG000", "title": "WBPA", "description": "Subjects will undergo to the Whole Body Periodic Acceleration platform for treatment (shaking period) for 45 min."}, {"id": "OG001", "title": "Sham WBPA", "description": "Subjects will be resting on the platform without any WBPA."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "45"}]}], "classes": [{"title": "Smokers n=15,15", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.85", "spread": "2.33"}, {"groupId": "OG001", "value": "-1.43", "spread": "2.8"}]}]}, {"title": "Controls N=15, 15", "categories": [{"measurements": [{"groupId": "OG000", "value": "17.93", "spread": "2.08"}, {"groupId": "OG001", "value": "4.03", "spread": "0.8"}]}]}, {"title": "Asthma N=15,15", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.96", "spread": "2.06"}, {"groupId": "OG001", "value": "1.65", "spread": "0.8"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Whole Body Periodic Acceleration (WBPA)", "description": "Whole Body Periodic Acceleration (WBPA) in spinal axis (pGz) will be administered with a platform that resembles a bed. The platform moves in a repetitive head-to-foot direction at 140 times a minute, producing 0.22 g. These settings have been shown to release NO into the circulation.\n\nWhole Body Periodic Acceleration (WBPA): Subjects will undergo to the Whole Body Periodic Acceleration platform for treatment (shaking period) for 45 min.", "seriousNumAffected": 0, "seriousNumAtRisk": 45, "otherNumAffected": 0, "otherNumAtRisk": 45}, {"id": "EG001", "title": "Sham WBPA", "description": "The subjects will rest for 45 minutes in the Whole Body Periodic Acceleration (WBPA) platform without movement as a control challenge.\n\nSham WBPA: The subjects will rest for 45 minutes in the Whole Body Periodic Acceleration (WBPA) platform without movement as a control challenge.", "seriousNumAffected": 0, "seriousNumAtRisk": 45, "otherNumAffected": 0, "otherNumAtRisk": 45}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Adam Wanner, MD", "organization": "University of Miami", "email": "awanner@med.miami.edu", "phone": "(305) 243-2568"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"browseLeaves": [{"id": "M4556", "name": "Asthma", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M3767", "name": "Albuterol", "relevance": "LOW"}, {"id": "M12507", "name": "Nitric Oxide", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}]}}, "hasResults": true}